These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15816442)

  • 1. Multimodality approach towards advanced rectal carcinoma. "Its efficacy and safety".
    Lygidakis NJ; Safioleas M
    Hepatogastroenterology; 2005; 52(62):385-90. PubMed ID: 15816442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
    Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
    Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer.
    Baik SH; Kim NK; Lee YC; Kim H; Lee KY; Sohn SK; Cho CH
    Ann Surg Oncol; 2007 Feb; 14(2):462-9. PubMed ID: 17096053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short course of preoperative radiotherapy improves prognosis of operable rectal carcinoma: a case control study.
    Penopoulos V; Handolias M; Avgerinos A; Maris T; Ilias T; Issopoulos N; Christianopoulos G; Betsis D; Vrettou E; Kitis G; Pistevou K
    Hepatogastroenterology; 2008; 55(85):1280-7. PubMed ID: 18795673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life after transanal endoscopic microsurgery and total mesorectal excision in early rectal cancer.
    Doornebosch PG; Tollenaar RA; Gosselink MP; Stassen LP; Dijkhuis CM; Schouten WR; van de Velde CJ; de Graaf EJ
    Colorectal Dis; 2007 Jul; 9(6):553-8. PubMed ID: 17573752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
    Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
    Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
    J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
    Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival and recurrences after total nerve-sparing surgery for rectal cancer.
    Peparini N; Maturo A; Di Matteo FM; Mele R; Benedetti F; Di Matteo G
    Hepatogastroenterology; 2006; 53(72):850-3. PubMed ID: 17153439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after the introduction of a multimodality treatment program for locally advanced rectal cancer.
    Palmer G; Martling A; Blomqvist L; Cedermark B; Holm T
    Eur J Surg Oncol; 2005 Sep; 31(7):727-34. PubMed ID: 15979271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laparoscopic rectal excision for cancer using total mesorectaol excision (TME). Long term outcome of a series of 179 patients].
    Lechaux D; Redon Y; Trebuchet G; Lecalve JL; Campion JP; Meunier B
    Ann Chir; 2005 Apr; 130(4):224-34. PubMed ID: 15847857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired anastomotic healing after preoperative radiotherapy followed by anterior resection for treatment of rectal carcinoma.
    Vermeulen J; Lange JF; van der Harst E
    S Afr J Surg; 2006 Feb; 44(1):12, 14-6. PubMed ID: 16619985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient's age and long-term outcome.
    Szynglarewicz B; Matkowski R; Maciejczyk A; Kasprzak P; Forgacz J; Pudelko M
    J Gastrointestin Liver Dis; 2008 Mar; 17(1):49-52. PubMed ID: 18392244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.